Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Cross-Sectional Serological Profile Anti-AChR by ELISA of a Brazilian Cohort of Patients With Suspected Myasthenia Gravis.

Created on 17 Nov 2026

Authors

Lucas Grobério Moulim de Moraes, Manoella Guerra de Albuquerque Bueno, Amanda Vitoria Freire de Oliveira, Giuliana França Teixeira Mandia Grossi, Milena Bongiorno Levignali, Carolina Lavigne Moreira, André Cleriston José Dos Santos, Rodrigo Siqueira Soares Frezatti, Claudia Ferreira da Rosa Sobreira, Wilson Marques Junior, Pedro José Tomaselli

Published in

Journal of immunology research. Volume 2026. Issue 1.

Abstract

Myasthenia gravis (MG) is most commonly mediated by antibodies against the acetylcholine receptor (AChR). Although radioimmunoprecipitation assay (RIPA) is the reference standard, enzyme-linked immunosorbent assay (ELISA) is widely used in routine practice, particularly in low- and middle-income settings, despite moderate sensitivity.
We retrospectively reviewed patients investigated for suspected myasthenic syndromes who underwent anti-AChR IgG testing by ELISA between 2017 and 2025 at a tertiary MG center in Brazil. Demographic, clinical, electrophysiological, and serological data were analyzed. Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis and multivariable logistic regression. Associations between antibody status and titers with MG phenotype, MGFA class, and MG-ADL scores were evaluated.
Among 321 individuals, 212 (66.0%) were diagnosed with MG. Anti-AChR positivity was strongly associated with MG (p  < 0.001), with observed sensitivity of 64.9% and specificity of 98.2%. Overall discriminative performance was high (area under the curve [AUC] 0.844). Antibody titers were significantly higher in MG versus non-MG patients (p  < 0.001) and in generalized versus ocular MG. Seropositivity was more frequent in very late-onset (LO) MG (p = 0.001). Ocular and bulbar presentations and non-Caucasian ethnicity were independently associated with MG; repetitive nerve stimulation positivity showed the strongest association, although this is partly attributable to its inclusion in the diagnostic definition. Antibody positivity correlated with greater disease severity (MGFA ≥ IIb and higher MG-ADL scores), although correlations between titers and severity were modest. Immunotherapy was not associated with reduced seropositivity.
Anti-AChR ELISA showed excellent specificity and good diagnostic discrimination, with moderate sensitivity in this real-world cohort. Because ELISA-negative samples were not retested by RIPA or cell-based assays (CBAs), this sensitivity should not be extrapolated to anti-AChR antibody testing overall.

PMID:
43042520
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement